BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37584547)

  • 1. MUC1 promotes lymph node metastasis in esophageal squamous cell carcinoma by downregulating DNAJB6 expression.
    Ma G; Liu X; Shi M
    Environ Toxicol; 2024 Jan; 39(1):9-22. PubMed ID: 37584547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma.
    Jiang B; Zhao Y; Shi M; Song L; Wang Q; Qin Q; Song X; Wu S; Fang Z; Liu X
    Dig Dis Sci; 2020 Jul; 65(7):1999-2008. PubMed ID: 31701262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1.
    Shi M; Chen D; Yang D; Liu XY
    J Exp Clin Cancer Res; 2015 Dec; 34():149. PubMed ID: 26667143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
    Liang W; Wang C; Wang J; Zhang M
    Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
    Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
    Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
    Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
    Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
    Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
    Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
    Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
    Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
    Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
    Wang Y; Liao X; Ye Q; Huang L
    Sci China Life Sci; 2018 Nov; 61(11):1389-1395. PubMed ID: 30076562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
    Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
    [No Abstract]   [Full Text] [Related]  

  • 15. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
    Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T
    Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels.
    Chen S; Lin X; He R; Zhang W; Kang M; Xu R
    Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MUC1-C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma.
    GongSun X; Zhao Y; Jiang B; Xin Z; Shi M; Song L; Qin Q; Wang Q; Liu X
    J Cell Physiol; 2019 Jul; 234(7):12019-12028. PubMed ID: 30523643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.